1.
Interleukin 22 (IL-22) As Biomarker For Rheumatoid Arthritis In Iraqi Population. Journal of Pharmaceutical Negative Results [Internet]. 2022 Oct. 4 [cited 2026 Jun. 6];:209-12. Available from: https://www.pnrjournal.com/index.php/home/article/view/1220